TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28508728

Group type: EXPERIMENTAL
Intervention: Identical circulating clonotypes in plasma
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: High International Prognostic Index (IPI) scores of 3-4
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Lymphoma-specific clonotypes
Number of subjects: 51
Study: 28508945

Group type: EXPERIMENTAL
Intervention: Cryoablation combined with allogenic NK cell immunotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Simple cryoablation
Number of subjects: 60
Study: 28510797

Group type: EXPERIMENTAL
Intervention: Morphine-3-Glucuronide (M3G)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Morphine-6-Glucuronide (M6G)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: M6G
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: M3G
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 20
Study: 28511653

Group type: EXPERIMENTAL
Intervention: Nirmal Bharat Abhiyan community mobilisation activities
Number of subjects: 80
Study: 28511673

Group type: EXPERIMENTAL
Intervention: Vismodegib 150 mg orally once daily until disease progression or intolerable toxicity
Number of subjects: 104
Study: 28511692

Group type: EXPERIMENTAL
Intervention: 1 μg paricalcitol daily
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 2 μg paricalcitol daily
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 28511695

Group type: EXPERIMENTAL
Intervention: Relative VPA thresholds
Number of subjects: 1076

Group type: COMPARATOR
Intervention: Absolute VPA thresholds
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: Relative MVPA thresholds
Number of subjects: 1076

Group type: COMPARATOR
Intervention: Absolute MVPA thresholds
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: Relative MVPA recommendation
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: Relative VPA recommendation
Number of subjects: 1076

Group type: COMPARATOR
Intervention: Absolute MVPA, MPA or VPA recommendations
Number of subjects: 1076
Study: 28511703

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 50
Study: 28511709

Group type: EXPERIMENTAL
Intervention: Tandem high-dose chemotherapy and autologous stem cell transplantation (HDCT/auto-SCT) after nine cycles of induction chemotherapy.
Number of subjects: 54
Study: 28512111

Group type: EXPERIMENTAL
Intervention: Pokémon GO participation
Number of subjects: 167
Study: 28512116

Group type: COMPARATOR
Intervention: Surgery on Tuesday
Number of subjects: 106473

Group type: COMPARATOR
Intervention: Surgery on Wednesday
Number of subjects: 106473

Group type: COMPARATOR
Intervention: Surgery on Thursday
Number of subjects: 106473

Group type: COMPARATOR
Intervention: Surgery on Friday
Number of subjects: 106473

Group type: COMPARATOR
Intervention: Surgery on Saturday/Sunday
Number of subjects: 106473

Group type: COMPARATOR
Intervention: Elective surgery on Tuesday
Number of subjects: 106473

Group type: COMPARATOR
Intervention: Elective surgery on Wednesday
Number of subjects: 106473

Group type: COMPARATOR
Intervention: Elective surgery on Thursday
Number of subjects: 106473

Group type: COMPARATOR
Intervention: Elective surgery on Friday
Number of subjects: 106473

Group type: COMPARATOR
Intervention: Elective surgery on Saturday/Sunday
Number of subjects: 106473
Study: 28512443

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) at 2 mA applied to the left dorsolateral prefrontal cortex and left temporal cortex.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham stimulation (control group).
Number of subjects: 30
Study: 28513244

Group type: EXPERIMENTAL
Intervention: Physical activity in obese subjects with metabolic syndrome (MO)
Number of subjects: 795

Group type: COMPARATOR
Intervention: Physical activity in obese subjects without metabolic syndrome (NMO)
Number of subjects: 795
Study: 28514251

Group type: EXPERIMENTAL
Intervention: Portal flow modulation
Number of subjects: 274

Group type: COMPARATOR
Intervention: Unmodulated subjects
Number of subjects: 274
Study: 28514281

Group type: EXPERIMENTAL
Intervention: Acute hyperinsulinemia
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (non-HIV-infected individuals)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (HIV-infected individuals)
Number of subjects: 30
Study: 28514773

Group type: EXPERIMENTAL
Intervention: Autologous hematopoietic stem cell transplantation using non-frozen peripheral blood stem cells (PBSCs) with conditioning of cyclophosphamide and rituximab.
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Autologous hematopoietic stem cell transplantation using non-frozen PBSCs.
Number of subjects: 286
Study: 28514929

Group type: EXPERIMENTAL
Intervention: Image-guided accelerated hypofractionated proton therapy (AHPT) at 70Gy(RBE) in 28 fractions for low-risk disease
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Image-guided accelerated hypofractionated proton therapy (AHPT) at 72.5Gy(RBE) in 29 fractions for intermediate-risk disease
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Image-guided accelerated hypofractionated proton therapy (AHPT)
Number of subjects: 215
Study: 28514979

Group type: EXPERIMENTAL
Intervention: Prophylactic exchange of central venous catheters
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no prophylactic exchange)
Number of subjects: 0
Study: 28515062

Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 0
Study: 28515067

Group type: EXPERIMENTAL
Intervention: Carrot consumption
Number of subjects: 0
Study: 28515069

Group type: EXPERIMENTAL
Intervention: long-chain PUFA-related genotypes
Number of subjects: 0
Study: 28515092

Group type: EXPERIMENTAL
Intervention: Neutrophils with a conventional segmented nucleus
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Neutrophils with a banded nucleus
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: T-cell-suppressing CD62L neutrophils
Number of subjects: 3
Study: 28515099

Group type: EXPERIMENTAL
Intervention: Delta NT-proBNP (baseline to 6 months)
Number of subjects: 1665

Group type: EXPERIMENTAL
Intervention: Delta hs-CRP (baseline to 6 months)
Number of subjects: 1665
Study: 28515106

Group type: EXPERIMENTAL
Intervention: 2-h accelerated diagnostic protocol (2h-ADP) combining hs-cTn, electrocardiogram, and a risk score
Number of subjects: 2525

Group type: COMPARATOR
Intervention: 2-h algorithm based exclusively on hs-cTn concentrations and their absolute changes
Number of subjects: 2525
Study: 28515192

Group type: EXPERIMENTAL
Intervention: Screening model for excessive gambling practices based on gambling behaviours observed on French gambling websites.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Score to predict whether a gambler is problematic or not, developed from the Canadian Problem Gambling Index and real gambling data.
Number of subjects: 0
Study: 28515269

Group type: EXPERIMENTAL
Intervention: Seal oil omega-3 polyunsaturated fatty acids (ω-3 PUFA) supplementation (10 mL·d)
Number of subjects: 40
Study: 28515791

Group type: EXPERIMENTAL
Intervention: Vildagliptin
Number of subjects: 42

Group type: COMPARATOR
Intervention: Gliclazide modified release (MR)
Number of subjects: 42
Study: 28515798

Group type: EXPERIMENTAL
Intervention: DNA methylation sites (cg06642177, cg07786668, cg17218495)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control group (no MI)
Number of subjects: 192
Study: 28516737

Group type: EXPERIMENTAL
Intervention: Iron status intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 28521737

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet Adherence Screener (MEDAS)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Higher fish consumption (at least 3 portions)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Food Frequency Questionnaire (FFQ)
Number of subjects: 68
Study: 28521762

Group type: EXPERIMENTAL
Intervention: Transcutaneous supraorbital nerve stimulation (t-SNS) with Cefaly® for 3 months
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Transcutaneous supraorbital nerve stimulation (t-SNS) with Cefaly®
Number of subjects: 35
Study: 28521785

Group type: EXPERIMENTAL
Intervention: Expect With Me (group prenatal care)
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Individual care (control group)
Number of subjects: 3000
Study: 28521822

Group type: EXPERIMENTAL
Intervention: BG-MnIL patients (34.6% prevalence)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: HVMs presence in BG-MnIL patients
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: IDA presence in BG-MnIL patients
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: IDA presence
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: IDA after adjustment for confounders
Number of subjects: 307
Study: 28521888

Group type: EXPERIMENTAL
Intervention: Lipid-rich plaque (LRP) detected in nonculprit regions
Number of subjects: 1474

Group type: COMPARATOR
Intervention: No lipid-rich plaque (LRP) detected
Number of subjects: 1474

Group type: EXPERIMENTAL
Intervention: LRP presence
Number of subjects: 1474

Group type: EXPERIMENTAL
Intervention: Acute coronary syndrome at index presentation
Number of subjects: 1474

Group type: EXPERIMENTAL
Intervention: Interruption of statin use ≥1 year
Number of subjects: 1474

Group type: EXPERIMENTAL
Intervention: LRP in patients with NC-MACE
Number of subjects: 1474
Study: 28522096

Group type: EXPERIMENTAL
Intervention: Delayed sleep-wake phase disorder (DSWPD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 40
Study: 28522110

Group type: EXPERIMENTAL
Intervention: Gemcitabine, busulfan, and melphalan
Number of subjects: 74

Group type: COMPARATOR
Intervention: Melphalan (control)
Number of subjects: 74
Study: 28522573

Group type: EXPERIMENTAL
Intervention: Lenalidomide, melphalan, and dexamethasone (6 cycles every 4 weeks)
Number of subjects: 50
Study: 28522574

Group type: EXPERIMENTAL
Intervention: Nilotinib, oral administration, monitored within three hours of administration.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nilotinib, oral administration, monitored within seven days.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy donors (control group), not treated with nilotinib.
Number of subjects: 0
Study: 28522576

Group type: EXPERIMENTAL
Intervention: Natural killer cells count
Number of subjects: 51
Study: 28522645

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 0
Study: 28522741

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 28523161

Group type: EXPERIMENTAL
Intervention: Heparin sodium 5,000 U, bid preoperatively upon admission
Number of subjects: 58
Study: 28523482

Group type: EXPERIMENTAL
Intervention: Patient-driven titration of BIAsp 30
Number of subjects: 155

Group type: COMPARATOR
Intervention: Physician-driven titration of BIAsp 30
Number of subjects: 155
Study: 28523582

Group type: EXPERIMENTAL
Intervention: Integrin-targeting radiopharmaceuticals (200 MBq injection)
Number of subjects: 0
Study: 28524735

Group type: EXPERIMENTAL
Intervention: Prepregnancy nutritional body mass index (BMI)
Number of subjects: 1654
Study: 28525293

Group type: EXPERIMENTAL
Intervention: Information received from physicians
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Information received from books
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Information received from the Internet
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Information received from dietitians
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Information received from nurses
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Information received from other sources
Number of subjects: 355
Study: 28525370

Group type: EXPERIMENTAL
Intervention: Metronomic vinorelbine (60 mg on Day 1, 30 mg on Day 2, and 60 mg on Day 4 weekly until progression)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metronomic vinorelbine
Number of subjects: 12
Study: 28525389

Group type: EXPERIMENTAL
Intervention: Olaparib
Number of subjects: 265

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265
Study: 28525886

Group type: EXPERIMENTAL
Intervention: Radial access (RA)
Number of subjects: 1820

Group type: COMPARATOR
Intervention: Femoral access (FA)
Number of subjects: 1820
Study: 28526003

Group type: EXPERIMENTAL
Intervention: BRFQ (Basic Research Factors Questionnaire)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BRFQ
Number of subjects: 0
Study: 28526012

Group type: EXPERIMENTAL
Intervention: Fertility preserving procedures
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Management of breast cancer survivors achieving a pregnancy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Survival outcomes, fetal, obstetrical and paediatric care
Number of subjects: 100
Study: 28526024

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study: 28526027

Group type: EXPERIMENTAL
Intervention: Inter-institutional referral
Number of subjects: 34319

Group type: COMPARATOR
Intervention: Not referred
Number of subjects: 34319
Study: 28526031

Group type: EXPERIMENTAL
Intervention: 12-week physical activity intervention
Number of subjects: 20
Study: 28526489

Group type: EXPERIMENTAL
Intervention: Intravitreous injection of AAV2-sFLT01
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 19
Study: 28526542

Group type: EXPERIMENTAL
Intervention: Patients with CKD stages 4 and 5
Number of subjects: 3352

Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 3352

Group type: EXPERIMENTAL
Intervention: Lower eGFR
Number of subjects: 3352

Group type: EXPERIMENTAL
Intervention: Current smoking
Number of subjects: 3352

Group type: EXPERIMENTAL
Intervention: Left ventricular ejection fraction
Number of subjects: 3352

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus treated with oral medication or insulin
Number of subjects: 3352

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 3352

Group type: EXPERIMENTAL
Intervention: Peripheral artery disease
Number of subjects: 3352

Group type: EXPERIMENTAL
Intervention: Coronary status
Number of subjects: 3352

Group type: EXPERIMENTAL
Intervention: eGFR reduction of 10ml/min/1.73m²
Number of subjects: 3352
Study: 28526664

Group type: EXPERIMENTAL
Intervention: Health coaching session plus tailored SMS text messages
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no coaching or SMS text messages)
Number of subjects: 60
Study: 28526673

Group type: EXPERIMENTAL
Intervention: Computer game-based rehabilitation platform (CGR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active control arm
Number of subjects: 0
Study: 28527133

Group type: EXPERIMENTAL
Intervention: TAK-264 1.8 mg/kg
Number of subjects: 43
Study: 28528010

Group type: EXPERIMENTAL
Intervention: Sustained-Release Bimatoprost Ocular Ring
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 28528200

Group type: EXPERIMENTAL
Intervention: Severe asthma (SA)
Number of subjects: 0
Study: 28528221

Group type: EXPERIMENTAL
Intervention: Perinatal model
Number of subjects: 724

Group type: EXPERIMENTAL
Intervention: 36-week model
Number of subjects: 724

Group type: EXPERIMENTAL
Intervention: Bronchopulmonary dysplasia (BPD)
Number of subjects: 724

Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 724
Study: 28528431

Group type: EXPERIMENTAL
Intervention: Rapid rest/regadenoson stress CMR perfusion imaging protocol
Number of subjects: 26

Group type: COMPARATOR
Intervention: X-ray coronary angiography
Number of subjects: 26
Study: 28528767

Group type: EXPERIMENTAL
Intervention: Radial access (RA)
Number of subjects: 8404

Group type: COMPARATOR
Intervention: Femoral access (FA)
Number of subjects: 8404
Study: 28528875

Group type: EXPERIMENTAL
Intervention: Central systolic BP
Number of subjects: 1599

Group type: EXPERIMENTAL
Intervention: Central pulse pressure (PP)
Number of subjects: 1599

Group type: COMPARATOR
Intervention: Brachial systolic BP
Number of subjects: 1599

Group type: COMPARATOR
Intervention: Central augmentation pressure
Number of subjects: 1599

Group type: EXPERIMENTAL
Intervention: E/E' and other echocardiographic parameters
Number of subjects: 1599
Study: 28528917

Group type: EXPERIMENTAL
Intervention: Pazopanib 600mg daily p.o. and metronomic cyclophosphamide 50mg daily p.o.
Number of subjects: 16
Study: 28529313

Group type: EXPERIMENTAL
Intervention: Histamine dihydrochloride and low-dose IL-2
Number of subjects: 81
Study: 28529534

Group type: EXPERIMENTAL
Intervention: High saturated fat test meals with milk fat globule membrane (MFGM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High saturated fat test meals without MFGM
Number of subjects: 0
Study: 28529748

Group type: EXPERIMENTAL
Intervention: Local modulated electro-hyperthermia (mEHT) combined with traditional Chinese medicine (TCM) 'Shi Pi' herbal decoction, applied for 60 min every second day for 4 weeks (14 sessions); TCM decoction administered orally at 400 ml daily.
Number of subjects: 260

Group type: COMPARATOR
Intervention: Standard intraperitoneal chemoinfusion (IPCI) with cisplatin (30-60 mg) and fluorouracil (500-600 mg/m2).
Number of subjects: 260
Study: 28530154

Group type: EXPERIMENTAL
Intervention: EEG-guided method
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: TMS-guided method
Number of subjects: 47
Study: 28530469

Group type: EXPERIMENTAL
Intervention: Calcein acetoxymethyl (AM) dye for detecting vital bacteria; applied for 5 min incubation.
Number of subjects: 53

Group type: COMPARATOR
Intervention: Colony-forming unit counting (control).
Number of subjects: 53
Study: 28531175

Group type: EXPERIMENTAL
Intervention: High-dose liposomal amphotericin B (L-AmB) 10 mg/kg/week for 2 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Matched untreated controls
Number of subjects: 21
Study: 28531305

Group type: EXPERIMENTAL
Intervention: GADA (Glutamic Acid Decarboxylase)
Number of subjects: 994

Group type: EXPERIMENTAL
Intervention: IAA (Insulin Autoantibodies)
Number of subjects: 994

Group type: EXPERIMENTAL
Intervention: Overall progression to multiple autoantibodies
Number of subjects: 994

Group type: EXPERIMENTAL
Intervention: Age breakpoints for GADA
Number of subjects: 994

Group type: EXPERIMENTAL
Intervention: Age breakpoints for IAA
Number of subjects: 994
Study: 28531309

Group type: EXPERIMENTAL
Intervention: HIV antiretroviral therapy (ARV)
Number of subjects: 65
Study: 28531455

Group type: EXPERIMENTAL
Intervention: Oats without sucrose
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Oats plus sucrose
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (Cream of Rice)
Number of subjects: 38
Study: 28531881

Group type: EXPERIMENTAL
Intervention: CAP7.1 (45, 90, 150, and 200 mg/m²)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: CAP7.1 (intravenous infusion for 5 consecutive days)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: CAP7.1
Number of subjects: 19
Study: 28532239

Group type: EXPERIMENTAL
Intervention: Prophylactic recombinant factor VIII (rFVIII)
Number of subjects: 183
Study: 28532434

Group type: EXPERIMENTAL
Intervention: NmA isolates from Cluster 1
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: NmA isolates from Cluster 2
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Invasive meningococcal isolates
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Carried NmA isolates
Number of subjects: 23
Study: 28532446

Group type: EXPERIMENTAL
Intervention: Stunting at birth
Number of subjects: 5558

Group type: EXPERIMENTAL
Intervention: Current stunting
Number of subjects: 5558

Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 5558

Group type: EXPERIMENTAL
Intervention: Stunting at birth by race
Number of subjects: 5558

Group type: EXPERIMENTAL
Intervention: Stunting at birth by jurisdiction income level
Number of subjects: 5558

Group type: EXPERIMENTAL
Intervention: Current stunting by jurisdiction income level
Number of subjects: 5558

Group type: EXPERIMENTAL
Intervention: Association between stunting at birth and current stunting
Number of subjects: 5558

Group type: EXPERIMENTAL
Intervention: Current stunting and obesity
Number of subjects: 5558

Group type: EXPERIMENTAL
Intervention: Dual burden of malnutrition
Number of subjects: 5558
Study: 28532454

Group type: EXPERIMENTAL
Intervention: Peripheral blood neutrophils from stable COPD patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neutrophils from one COPD group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy age-matched controls
Number of subjects: 0
Study: 28532489

Group type: EXPERIMENTAL
Intervention: Self-concept for physical activity
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Neighborhood social life
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Neighborhood satisfaction
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Average social life
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Self-concept for physical activity (within-person effect)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Neighborhood social life (within-person effect)
Number of subjects: 224
Study: 28532759

Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 28533916

Group type: EXPERIMENTAL
Intervention: Intravenous pantoprazole 1 mg/kg once daily until no longer needing mechanical ventilation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Identical placebo
Number of subjects: 120
Study: 28533941

Group type: EXPERIMENTAL
Intervention: Blinatumomab
Number of subjects: 36
Study: 28534110

Group type: EXPERIMENTAL
Intervention: World Health Organisation's Disability Assessment Schedule 2.0
Number of subjects: 262
Study: 28535181

Group type: EXPERIMENTAL
Intervention: Everolimus 5 mg daily combined with paclitaxel 175 mg/m2 and carboplatin AUC 5 every 3 weeks for a maximum of four cycles followed by maintenance everolimus 5 mg daily until progression
Number of subjects: 49
Study: 28535298

Group type: EXPERIMENTAL
Intervention: Ledipasvir-Sofosbuvir plus Ribavirin (90 mg and 400 mg) for 12 weeks
Number of subjects: 111
Study: 28535817

Group type: EXPERIMENTAL
Intervention: Intravenous transplantation of autologous bone marrow mesenchymal stromal cells (BMMSCs)
Number of subjects: 6
Study: 28536088

Group type: EXPERIMENTAL
Intervention: Txt2Prevent intervention (text messaging program)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 76